Akademska digitalna zbirka SLovenije - logo
E-viri
Celotno besedilo
Recenzirano Odprti dostop
  • Non-occlusive Mesenteric Is...
    Reichling, Cynthia; Nobile, Leda; Pezzullo, Martina; Navez, Julie; Bachir, Najla; D’Haene, Nicky; Maris, Calliope; Musala, Carmen; Fernandez Y. Viesca, Michael; Grimaldi, David; Delhaye, Myriam

    Digestive diseases and sciences, 04/2020, Letnik: 65, Številka: 4
    Journal Article

    Background Vascular complications of severe acute pancreatitis are well known and largely described unlike non-occlusive mesenteric ischemia, which is a rare and potentially fatal complication. Non-occlusive mesenteric ischemia is an acute mesenteric ischemia without thrombotic occlusion of blood vessels, poorly described as a complication of acute pancreatitis. Methods We retrospectively reviewed a prospectively maintained registry of all pancreatic diseases referred to our center from 2013 to 2018, in order to determine the causes of early death. We identified three patients who died within 48 h after hospital admission from severe acute pancreatitis complicated by irreversible non-occlusive mesenteric ischemia. Their clinical presentation, management, and outcomes were herein reported. Results Three consecutive patients with severe acute pancreatitis developed non-occlusive mesenteric ischemia within the first 5 days after onset of symptoms and died 48 h after non-occlusive mesenteric ischemia diagnosis despite optimal intensive care management and surgery, giving a prevalence of 3/609 (0.5%). Symptoms were unspecific with consequently potential delayed diagnosis and management. High doses of norepinephrine required for hemodynamic support ( n  = 3) potentially leading to splanchnic vessels vasoconstriction, transient hypotension ( n  = 3), and previous severe ischemic cardiomyopathy ( n  = 1) could be involved as precipitating factors of non-occlusive mesenteric ischemia. Conclusion Non-occlusive mesenteric ischemia can be a fatal complication of acute pancreatitis but is also challenging to diagnose. Priority is to reestablish a splanchno-mesenteric perfusion flow. Surgery should be offered in case of treatment failure or deterioration but is still under debate in early stage, to interrupt the vicious circle of intestinal hypoperfusion and ischemia.